Mechanisms of nephroprotective effect of mitochondria-targeted antioxidants under rhabdomyolysis and ischemia/reperfusion

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1812, Issue 1, 2011, Pages 77-86

  Plotnikov, E Y ^a,b   Chupyrkina, A A ^a,b   Jankauskas, S S ^a,b   Pevzner, I B ^a,b   Silachev, D N ^a,b   Skulachev, V P ^a,b   Zorov, D B ^a,b  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

^b Institute of Mitoengineering   (Russian Federation)

Author keywords

Antioxidants; Cytochrome c; Erythropoietin; Glycogen synthase kinase; Ischemia; Kidney tubules; Lipid peroxidation; Mitochondria; Reactive oxygen species; Rhabdomyolysis

Indexed keywords

ANTIOXIDANT; CYTOCHROME C; ERYTHROPOIETIN; GLYCOGEN SYNTHASE KINASE 3BETA; PLASTOQUINONE; REACTIVE OXYGEN METABOLITE; RHODAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONJUGATION; CONTROLLED STUDY; LIPID PEROXIDATION; MALE; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RENAL PROTECTION; REPERFUSION INJURY; RHABDOMYOLYSIS; URINARY EXCRETION;

ANIMALS; ANTIOXIDANTS; BLOTTING, WESTERN; CELLS, CULTURED; ERYTHROPOIETIN; GLYCOGEN SYNTHASE KINASE 3; KIDNEY; KIDNEY DISEASES; MALE; MICROSCOPY, CONFOCAL; MITOCHONDRIA; MOLECULAR STRUCTURE; OXIDATIVE STRESS; PHOSPHORYLATION; PLASTOQUINONE; PROTECTIVE AGENTS; RATS; REPERFUSION INJURY; RHABDOMYOLYSIS; RHODAMINES; SURVIVAL RATE;

ANIMALIA;

EID: 78650273335     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2010.09.008     Document Type: Article

References (53)

1. Chertow G.M., Soroko S.H., Paganini E.P., Cho K.C., Himmelfarb J., Ikizler T.A., Mehta R.L. Mortality after acute renal failure: models for prognostic stratification and risk adjustment. Kidney Int. 2006, 70:1120-1126.
2. Woodrow G., Turney J.H. Cause of death in acute renal failure. Nephrol. Dial. Transplant. 1992, 7:230-234.
3. McCarthy J.T. Prognosis of patients with acute renal failure in the intensive-care unit: a tale of two eras. Mayo Clin. Proc. 1996, 71:117-126.
4. Levy E.M., Viscoli C.M., Horwitz R.I. The effect of acute renal failure on mortality. A cohort analysis. JAMA 1996, 275:1489-1494.
5. Chertow G.M., Levy E.M., Hammermeister K.E., Grover F., Daley J. Independent association between acute renal failure and mortality following cardiac surgery. Am. J. Med. 1998, 104:343-348.
6. Polo-Romero F.J., Fernandez-Funez A., Broseta Viana L., Atienza M.P., Sanchez Gascon F. Effect of N-acetylcysteine on antioxidant status in glycerol-induced acute renal failure in rats. Ren. Fail. 2004, 26:613-618.
7. Rodrigo R., Bosco C., Herrera P., Rivera G. Amelioration of myoglobinuric renal damage in rats by chronic exposure to flavonol-rich red wine. Nephrol. Dial. Transplant. 2004, 19:2237-2244.
8. Singh D., Chander V., Chopra K. Protective effect of naringin, a bioflavonoid on glycerol-induced acute renal failure in rat kidney. Toxicology 2004, 201:143-151.
9. Aydogdu N., Atmaca G., Yalcin O., Batcioglu K., Kaymak K. Effects of exogenous melatonin on myoglobinuric acute renal failure in the rats. Ren. Fail. 2004, 26:479-486.
10. Chander V., Chopra K. Molsidomine, a nitric oxide donor and l-arginine protects against rhabdomyolysis-induced myoglobinuric acute renal failure. Biochim. Biophys. Acta 2005, 1723:208-214.
11. Aydogdu N., Atmaca G., Yalcin O., Taskiran R., Tastekin E., Kaymak K. Protective effects of l-carnitine on myoglobinuric acute renal failure in rats. Clin. Exp. Pharmacol. Physiol. 2006, 33:119-124.
12. Koyner J.L., Sher Ali R., Murray P.T. Antioxidants. Do they have a place in the prevention or therapy of acute kidney injury?. Nephron. Exp. Nephrol. 2008, 109:e109-e117.
13. Cocheme H.M., Kelso G.F., James A.M., Ross M.F., Trnka J., Mahendiran T., Asin-Cayuela J., Blaikie F.H., Manas A.R., Porteous C.M., Adlam V.J., Smith R.A., Murphy M.P. Mitochondrial targeting of quinones: therapeutic implications. Mitochondrion 2007, 7(Suppl):S94-S102.
14. Skulachev V.P. A biochemical approach to the problem of aging: "megaproject" on membrane-penetrating ions. The first results and prospects. Biochemistry (Mosc) 2007, 72:1385-1396.
15. Skulachev V.P., Anisimov V.N., Antonenko Y.N., Bakeeva L.E., Chernyak B.V., Erichev V.P., Filenko O.F., Kalinina N.I., Kapelko V.I., Kolosova N.G., Kopnin B.P., Korshunova G.A., Lichinitser M.R., Obukhova L.A., Pasyukova E.G., Pisarenko O.I., Roginsky V.A., Ruuge E.K., Senin I.I., Severina I.I., Skulachev M.V., Spivak I.M., Tashlitsky V.N., Tkachuk V.A., Vyssokikh M.Y., Yaguzhinsky L.S., Zorov D.B. An attempt to prevent senescence: a mitochondrial approach. Biochim. Biophys. Acta 2009, 1787:437-461.
16. Liberman E.A., Topaly V.P., Tsofina L.M., Jasaitis A.A., Skulachev V.P. Mechanism of coupling of oxidative phosphorylation and the membrane potential of mitochondria. Nature 1969, 222:1076-1078.
17. Antonenko Y.N., Roginsky V.A., Pashkovskaya A.A., Rokitskaya T.I., Kotova E.A., Zaspa A.A., Chernyak B.V., Skulachev V.P. Protective effects of mitochondria-targeted antioxidant SkQ in aqueous and lipid membrane environments. J. Membr. Biol. 2008, 222:141-149.
18. Bakeeva L.E., Barskov I.V., Egorov M.V., Isaev N.K., Kapelko V.I., Kazachenko A.V., Kirpatovsky V.I., Kozlovsky S.V., Lakomkin V.L., Levina S.B., Pisarenko O.I., Plotnikov E.Y., Saprunova V.B., Serebryakova L.I., Skulachev M.V., Stelmashook E.V., Studneva I.M., Tskitishvili O.V., Vasilyeva A.K., Victorov I.V., Zorov D.B., Skulachev V.P. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 2. Treatment of some ROS- and age-related diseases (heart arrhythmia, heart infarctions, kidney ischemia, and stroke). Biochemistry (Mosc) 2008, 73:1288-1299.
19. Agapova L.S., Chernyak B.V., Domnina L.V., Dugina V.B., Efimenko A.Y., Fetisova E.K., Ivanova O.Y., Kalinina N.I., Khromova N.V., Kopnin B.P., Kopnin P.B., Korotetskaya M.V., Lichinitser M.R., Lukashev A.L., Pletjushkina O.Y., Popova E.N., Skulachev M.V., Shagieva G.S., Stepanova E.V., Titova E.V., Tkachuk V.A., Vasiliev J.M., Skulachev V.P. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 3. Inhibitory effect of SkQ1 on tumor development from p53-deficient cells. Biochemistry (Mosc) 2008, 73:1300-1316.
20. Neroev V.V., Archipova M.M., Bakeeva L.E., Fursova A.Z.h., Grigorian E.N., Grishanova A.Y., Iomdina E.N., Ivashchenko Z.h.N., Katargina L.A., Khoroshilova-Maslova I.P., Kilina O.V., Kolosova N.G., Kopenkin E.P., Korshunov S.S., Kovaleva N.A., Novikova Y.P., Philippov P.P., Pilipenko D.I., Robustova O.V., Saprunova V.B., Senin I.I., Skulachev M.V., Sotnikova L.F., Stefanova N.A., Tikhomirova N.K., Tsapenko I.V., Shchipanova A.I., Zinovkin R.A., Skulachev V.P. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 4. Age-related eye disease. SkQ1 returns vision to blind animals. Biochemistry (Mosc) 2008, 73:1317-1328.
21. Anisimov V.N., Bakeeva L.E., Egormin P.A., Filenko O.F., Isakova E.F., Manskikh V.N., Mikhelson V.M., Panteleeva A.A., Pasyukova E.G., Pilipenko D.I., Piskunova T.S., Popovich I.G., Roshchina N.V., Rybina O.Y., Saprunova V.B., Samoylova T.A., Semenchenko A.V., Skulachev M.V., Spivak I.M., Tsybul'ko E.A., Tyndyk M.L., Vyssokikh M.Y., Yurova M.N., Zabezhinsky M.A., Skulachev V.P. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 5. SkQ1 prolongs lifespan and prevents development of traits of senescence. Biochemistry (Mosc) 2008, 73:1329-1342.
22. Plotnikov E.Y., Kazachenko A.V., Vyssokikh M.Y., Vasileva A.K., Tcvirkun D.V., Isaev N.K., Kirpatovsky V.I., Zorov D.B. The role of mitochondria in oxidative and nitrosative stress during ischemia/reperfusion in the rat kidney. Kidney Int. 2007, 72:1493-1502.
23. Plotnikov E.Y., Chupyrkina A.A., Pevzner I.B., Isaev N.K., Zorov D.B. Myoglobin causes oxidative stress, increase of NO production and dysfunction of kidney's mitochondria. Biochim. Biophys. Acta 2009, 1792:796-803.
24. Feldkamp T., Park J.S., Pasupulati R., Amora D., Roeser N.F., Venkatachalam M.A., Weinberg J.M. Regulation of the mitochondrial permeability transition in kidney proximal tubules and its alteration during hypoxia-reoxygenation. Am J Physiol Renal Physiol 2009, 297:F1632-F1646.
25. Skulachev V.P., Antonenko Y.N., Cherepanov D.A., Chernyak B.V., Izyumov D.S., Khailova L.S., Klishin S.S., Korshunova G.A., Lyamzaev K.G., Pletjushkina O.Y., Roginsky V.A., Rokitskaya T.I., Severin F.F., Severina I.I., Simonyan R.A., Skulachev M.V., Sumbatyan N.V., Sukhanova E.I., Tashlitsky V.N., Trendeleva T.A., Vyssokikh M.Y., Zvyagilskaya R.A. Prevention of cardiolipin oxidation and fatty acid cycling as two antioxidant mechanisms of cationic derivatives of plastoquinone (SkQs). Biochim. Biophys. Acta 2010, 1797:878-889.
26. Plotnikov E.Y., Silachev D.N., Chupyrkina A.A., Danshina M.I., Jankauskas S.S., Morosanova M.A., Stelmashook E.V., Vasileva A.K., Goryacheva E.S., Pirogov Y.A., Isaev N.K., Zorov D.B. New-generation skulachev ions exhibiting nephroprotective and neuroprotective properties. Biochemistry (Mosc) 2010, 75:145-150.
27. Zurovsky Y. Models of glycerol-induced acute renal failure in rats. J. Basic Clin. Physiol. Pharmacol. 1993, 4:213-228.
28. Mihara M., Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal. Biochem. 1978, 86:271-278.
29. Zager R.A., Johnson A.C., Hanson S.Y. Proximal tubular cytochrome c efflux: determinant, and potential marker, of mitochondrial injury. Kidney Int. 2004, 65:2123-2134.
30. Dobashi K., Singh I., Orak J.K., Asayama K., Singh A.K. Combination therapy of N-acetylcysteine, sodium nitroprusside and phosphoramidon attenuates ischemia-reperfusion injury in rat kidney. Mol. Cell. Biochem. 2002, 240:9-17.
31. Serviddio G., Romano A.D., Gesualdo L., Tamborra R., Di Palma A.M., Rollo T., Altomare E., Vendemiale G. Postconditioning is an effective strategy to reduce renal ischaemia/reperfusion injury. Nephrol. Dial. Transplant. 2008, 23:1504-1512.
32. Rouschop K.M., Leemans J.C. Ischemia-reperfusion treatment: opportunities point to modulation of the inflammatory response. Kidney Int. 2008, 73:1333-1335.
33. Chatterjee P.K. Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review. Naunyn Schmiedebergs Arch. Pharmacol. 2007, 376:1-43.
34. Plotnikov E.Y., Vasileva A.K., Arkhangelskaya A.A., Pevzner I.B., Skulachev V.P., Zorov D.B. Interrelations of mitochondrial fragmentation and cell death under ischemia/reoxygenation and UV-irradiation: protective effects of SkQ1, lithium ions and insulin. FEBS Lett. 2008, 582:3117-3124.
35. Zorov D.B., Filburn C.R., Klotz L.O., Zweier J.L., Sollott S.J. Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J. Exp. Med. 2000, 192:1001-1014.
36. Zorov D.B., Juhaszova M., Sollott S.J. Mitochondrial ROS-induced ROS release: an update and review. Biochim. Biophys. Acta 2006, 1757:509-517.
37. Zager R.A. Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int. 1996, 49:314-326.
38. Vanholder R., Sever M.S., Erek E., Lameire N. Rhabdomyolysis. J. Am. Soc. Nephrol. 2000, 11:1553-1561.
39. Zager R.A. Mitochondrial free radical production induces lipid peroxidation during myohemoglobinuria. Kidney Int. 1996, 49:741-751.
40. Reeder B.J., Sharpe M.A., Kay A.D., Kerr M., Moore K., Wilson M.T. Toxicity of myoglobin and haemoglobin: oxidative stress in patients with rhabdomyolysis and subarachnoid haemorrhage. Biochem. Soc. Trans. 2002, 30:745-748.
41. Anagnostou A., Lee E.S., Kessimian N., Levinson R., Steiner M. Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:5978-5982.
42. Digicaylioglu M., Bichet S., Marti H.H., Wenger R.H., Rivas L.A., Bauer C., Gassmann M. Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:3717-3720.
43. Brines M., Cerami A. Emerging biological roles for erythropoietin in the nervous system. Nat. Rev. Neurosci. 2005, 6:484-494.
44. Fliser D., Bahlmann F.H., deGroot K., Haller H. Mechanisms of disease: erythropoietin-an old hormone with a new mission?. Nat. Clin. Pract. Cardiovasc. Med. 2006, 3:563-572.
45. Sharples E.J., Yaqoob M.M. Erythropoietin in experimental acute renal failure. Nephron. Exp. Nephrol. 2006, 104:e83-e88.
46. Sutherland C., Leighton I.A., Cohen P. Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem. J. 1993, 296(Pt 1):15-19.
47. Juhaszova M., Zorov D.B., Kim S.H., Pepe S., Fu Q., Fishbein K.W., Ziman B.D., Wang S., Ytrehus K., Antos C.L., Olson E.N., Sollott S.J. Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J. Clin. Invest. 2004, 113:1535-1549.
48. Skulachev V.P. Role of uncoupled and non-coupled oxidations in maintenance of safely low levels of oxygen and its one-electron reductants. Q. Rev. Biophys. 1996, 29:169-202.
49. Ohori K., Miura T., Tanno M., Miki T., Sato T., Ishikawa S., Horio Y., Shimamoto K. Ser9 phosphorylation of mitochondrial GSK-3beta is a primary mechanism of cardiomyocyte protection by erythropoietin against oxidant-induced apoptosis. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:H2079-H2086.
50. Burger D., Xenocostas A., Feng Q.P. Molecular basis of cardioprotection by erythropoietin. Curr. Mol. Pharmacol. 2009, 2:56-69.
51. Toba H., Sawai N., Morishita M., Murata S., Yoshida M., Nakashima K., Morita Y., Kobara M., Nakata T. Chronic treatment with recombinant human erythropoietin exerts renoprotective effects beyond hematopoiesis in streptozotocin-induced diabetic rat. Eur. J. Pharmacol. 2009, 612:106-114.
52. Jelkmann W., Pagel H., Hellwig T., Fandrey J. Effects of antioxidant vitamins on renal and hepatic erythropoietin production. Kidney Int. 1997, 51:497-501.
53. Neumcke I., Schneider B., Fandrey J., Pagel H. Effects of pro- and antioxidative compounds on renal production of erythropoietin. Endocrinology 1999, 140:641-645.